Psychedelic Drugs Market Projected to Reach $11.34 Billion by 2030 at a 15.1% CAGR

𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰

The Psychedelic Drugs Market was valued at USD 4.23 billion in 2023 and is expected to grow at a robust CAGR of 15.10% during the forecast period from 2024 to 2030, reaching USD 11.34 billion by 2030. The market's growth is driven by rising mental health concerns and innovative research in therapeutic applications.

The Psychedelic Drugs Market is projected to exhibit significant growth during the forecast period, fueled by increasing clinical research and growing awareness of the therapeutic benefits of these drugs. This press release explores the market's CAGR, market size, country-specific developments, and recent key advancements.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/124231/

𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐕𝐢𝐞𝐭𝐧𝐚𝐦

Vietnam is emerging as a significant market for psychedelic drugs due to increasing clinical trials and regulatory acceptance. The government's progressive stance on mental health issues has encouraged companies like 𝐌𝐢𝐧𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐈𝐧𝐜. to explore partnerships within the region. Recent investments in healthcare infrastructure further highlight Vietnam's potential.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐓𝐡𝐚𝐢𝐥𝐚𝐧𝐝

Thailand's psychedelic drugs market is witnessing a shift towards natural psychedelics like psilocybin mushrooms. Regulatory advancements, such as allowing controlled use for medical purposes, are bolstering the market. Companies like 𝐂𝐲𝐛𝐢𝐧 𝐈𝐧𝐜. have shown interest in tapping into Thailand's market due to its growing mental health awareness.

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐉𝐚𝐩𝐚𝐧

Japan remains a conservative yet steadily growing market for psychedelic drugs. Companies such as 𝐂𝐨𝐦𝐩𝐚𝐬𝐬 𝐏𝐚𝐭𝐡𝐰𝐚𝐲𝐬 have entered strategic partnerships with Japanese firms to advance clinical trials. Regulatory hurdles remain a challenge but are being mitigated by increasing research collaborations.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/124231/

𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐂𝐡𝐢𝐧𝐚

China's rapidly evolving healthcare industry provides a fertile ground for psychedelic drug development. Investments by 𝐀𝐓𝐀𝐈 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 in research facilities signal a growing acceptance of these drugs for treating depression and PTSD. Recent studies highlight China's focus on advancing therapeutic applications.

𝐓𝐫𝐞𝐧𝐝𝐬 𝐚𝐧𝐝 𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐒𝐨𝐮𝐭𝐡 𝐊𝐨𝐫𝐞𝐚

South Korea's progressive stance on mental health issues has paved the way for psychedelic drugs to gain traction. Key players like 𝐁𝐞𝐜𝐤𝐥𝐞𝐲 𝐏𝐬𝐲𝐭𝐞𝐜𝐡 have initiated collaborations with local pharmaceutical companies, enhancing the availability of therapies. Regulatory updates are expected to further propel growth.

𝐆𝐫𝐨𝐰𝐭𝐡 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞

Singapore's market is characterized by strict regulations but a growing interest in alternative mental health treatments. Companies such as 𝐅𝐢𝐞𝐥𝐝 𝐓𝐫𝐢𝐩 𝐇𝐞𝐚𝐥𝐭𝐡 have begun exploring partnerships in the region. Singapore's advanced healthcare infrastructure makes it a promising market.

𝐓𝐨 𝐥𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞, 𝐬𝐢𝐦𝐩𝐥𝐲 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 :https://www.maximizemarketresearch.com/request-sample/124231/

𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬

The U.S. continues to dominate the global psychedelic drugs market, accounting for the largest revenue share in 2023. Key players like 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 & 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 and 𝐌𝐢𝐧𝐝𝐌𝐞𝐝 are at the forefront of FDA-approved clinical trials. Mergers and acquisitions, such as 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 & 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 acquiring smaller biotech firms, are shaping the competitive landscape.

𝐂𝐨𝐧𝐬𝐨𝐥𝐢𝐝𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞

Europe's market is growing steadily, driven by countries like the Netherlands and Germany. Companies like 𝐀𝐰𝐚𝐤𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 are leading the charge with innovative therapies. Recent mergers and acquisitions, such as 𝐂𝐨𝐦𝐩𝐚𝐬𝐬 𝐏𝐚𝐭𝐡𝐰𝐚𝐲𝐬 partnering with European mental health institutes, signify market consolidation.

𝐊𝐞𝐲 𝐑𝐞𝐜𝐞𝐧𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

𝐌𝐢𝐧𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐈𝐧𝐜. expanded its clinical trials to include psilocybin therapies in Asia-Pacific.

𝐂𝐨𝐦𝐩𝐚𝐬𝐬 𝐏𝐚𝐭𝐡𝐰𝐚𝐲𝐬 partnered with Japanese firms for advancing psychedelic drug trials.

𝐀𝐓𝐀𝐈 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 announced the establishment of a new research center in China to study therapeutic applications of psychedelic drugs.

𝐉𝐨𝐡𝐧𝐬𝐨𝐧 & 𝐉𝐨𝐡𝐧𝐬𝐨𝐧 acquired smaller biotech companies to strengthen its psychedelic drug portfolio.

𝐀𝐰𝐚𝐤𝐧 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 launched its first clinic in Europe, offering MDMA-assisted therapy.

𝐅𝐨𝐫 𝐚 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐨𝐯𝐞𝐫𝐯𝐢𝐞𝐰, 𝐜𝐥𝐢𝐜𝐤 𝐨𝐧 𝐭𝐡𝐞 𝐥𝐢𝐧𝐤 𝐩𝐫𝐨𝐯𝐢𝐝𝐞𝐝:https://www.maximizemarketresearch.com/market-report/psychedelic-drugs-market/124231/

𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

𝐛𝐲 𝐓𝐲𝐩𝐞

Lysergic Acid Diethylamide (LSD)
3,4-MethylEnedioxyMethamphetamine (Ecstasy)
Phencyclidine
Gamma Hydroxybutyric Acid (GHB)
Etamine
Ayahuasca
Salvia
Psilocybin
Others

𝐛𝐲 𝐏𝐚𝐭𝐢𝐞𝐧𝐭

Major Depressive Disorder
Resistant depression
Panic disorder
Post-traumatic stress disorder
Addiction
Narcolepsy
Others

𝐛𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞

Hospitals
Homecare
Specialty Clinics
Others

𝐏𝐬𝐲𝐜𝐡𝐞𝐝𝐞𝐥𝐢𝐜 𝐃𝐫𝐮𝐠𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬

1. Janssen Pharmaceuticals,
2. Hikma Pharmaceuticals PLC
3. COMPASS
4. Verrian
5. Pfizer Inc.
6. F. Hoffmann-La Roche Ltd.
7. Jazz Pharmaceuticals Inc.
8. PharmaTher Inc.
9. Avadel
10. Celon Pharma S.A.
11. NeuroRx, Inc.
12. usonainstitute.org
13. Celon Pharma S.A.
14. Red Light Holland
15. Neonmind Biosciences
16. Novamind
17. MindMed
18. Numinus
19. Entheon Biomedical

𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫 𝐖𝐡𝐚𝐭'𝐬 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠:

♦ Uk Dental Services Market https://www.maximizemarketresearch.com/market-report/uk-dental-services-market/222401/

♦ Us Death Care Market https://www.maximizemarketresearch.com/market-report/us-death-care-market/21986/

♦ Vcsel Market https://www.maximizemarketresearch.com/market-report/vcsel-market/11592/

♦ Ventilator Market Latin America https://www.maximizemarketresearch.com/market-report/ventilator-market-latin-america/1970/

♦ Wearable Medical Devices Market https://www.maximizemarketresearch.com/market-report/wearable-medical-devices-market/1358/

♦ Wearable Medical Devices Market Europe https://www.maximizemarketresearch.com/market-report/wearable-medical-devices-market-europe/2221/

♦ Wearable Medical Devices Market Middle East https://www.maximizemarketresearch.com/market-report/wearable-medical-devices-market-middle-east/2241/

♦ Wet Wipes Canister Market https://www.maximizemarketresearch.com/market-report/wet-wipes-canister-market/122981/

♦ Zonisamide Market https://www.maximizemarketresearch.com/market-report/zonisamide-market/148295/

♦ Neuropathic Pain Market https://www.maximizemarketresearch.com/market-report/global-neuropathic-pain-market/34992/

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

𝐀𝐛𝐨𝐮𝐭 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.